New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 10, 2014
05:42 EDTEWEdwards Lifesciences upgraded to Outperform from Market Perform at Wells Fargo
Wells Fargo upgraded Edwards Lifesciences citing a number of positive developments since it downgraded the stock in December 2013, including strong Q4 Sapien results outside the U.S. and the company's successful first-inman transcatheter mitral valve implants. Wells raised its price target range for shares to $82-$83 from $67-$69.
News For EW From The Last 14 Days
Check below for free stories on EW the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 31, 2014
12:50 EDTEWEuropean Society of Cardiology to hold a conference
Subscribe for More Information
August 24, 2014
21:54 EDTEWPiper Jaffray to hold a bus tour
Subscribe for More Information
August 21, 2014
08:29 EDTEWEdwards Lifesciences price target raised to $120 from $97 at JMP Securities
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use